Two Chinese vaccines made by Sinopharm received a stamp of approval from a prestigious medical journal. Following a two-month peer review, the Journal for American Medical Association (JAMA) recently published the clinical trial results for two Sinopharm jabs — codenamed WIV04 and HB02 — marking a key milestone in the fight against COVID-19. This places researchers in the China, the UAE, and other Arab countries who collaborated on trial at the forefront of vaccine development. More importantly, it puts to rest questions about the safety and efficacy of Sinopharm shots, which users the tried-and-tested inactivated-virus platform. China National Pharmaceutical Group Co., Ltd. (Sinopharm), a
Hence then, the article about sinopharm covid 19 vaccines what the latest study shows was published today ( ) and is available onGulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Sinopharm COVID-19 vaccines: What the latest study shows )